pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-100 |
Genomic Coordinates | chr11: 122152229 - 122152308 |
Synonyms | MIRN100, miR-100, MIR100 |
Description | Homo sapiens miR-100 stem-loop |
Comment | This sequence is localised to chromosome 11 and was named mir-100-11 in reference . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-100-3p | |||||||||||||||||||||||||||
Sequence | 48| CAAGCUUGUAUCUAUAGGUAUG |69 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ZFP3 | ||||||||||||||||||||
Synonyms | ZNF752 | ||||||||||||||||||||
Description | ZFP3 zinc finger protein | ||||||||||||||||||||
Transcript | NM_153018 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ZFP3 | |||||||||||||||||||||
3'UTR of ZFP3 (miRNA target sites are highlighted) |
>ZFP3|NM_153018|3'UTR 1 TCTGCAAAATAGGAAAGCTTTTAGTGGAAAAGCTAAAGTCCAACTTATTCATTTGTTCATAATATGCAAATATGCACCCC 81 AAGTATTCAAATCCAATGAATGGACAGAACCTCCTCTGTCCTCCCACTGATTTTAAATAGTTGGTTGAAGAAGATGAGGC 161 ACTTTTTTTTTTTTTTTTTTAAGCATTGGGGTCTTGCTCTGTTGCCCAGGATGGGATGCAGTGGCACAGTCGTAACTCAC 241 TGCTTCCTTGAACTCCTGGGCTCAAACAGTCCTCCTGCCTCAGCCTTCCAAATAGCTAGGACTGCAGGCACTAATGAGGC 321 ACTTTTATGAATTATTCATTGAGAGGTTTCAGTGTGCTAAGTTAAATCATAAAAGCTCTTTCAGGCCTTAATTTCCCCTC 401 TGTCCTTCCTTCCCCTTCTCCTCCCCCAGTGGATCACATAACAAACATTAAGGGTCTGTACCAGCCATCTTTCCTAAATT 481 ACTCTTCAGCAAAATTGTGGGAACAGGATTCCACCACCTCCTAAGAATGAGAGTTGACTCATTGACTGTTACCCCCTGAA 561 ATATTAGAAAGTCATAATTTAGAAGACACACCTCATTCTCCTGTCCACTGTTTAGCATTGGAATAATTTAGTAAGCTGTT 641 ATTAGCTTCAAAGTCGTCCAGCCCTGCTATGAAGTTACTTTAGAAGATGGCAGCATTAATGAAGAAGCAGGCTCATTTCA 721 CATCTGTCAGGCTTCCTTATTCATCTGAAGAGGCTGCCATGATGGAGGAACTGACAGGCAATTTACAACGGGATTATAAG 801 TGAAGGCCTTAGAATCCAGAGGGGCCGATTAGGCAACACCAGGGGATAAACAATTGAGGTCACACTGCTCGGCATGGGCA 881 GAAGCAGCTCTTCAGGAGCTGTCCACACTTCAGGGGTGCTCAGACTGACTGCTCCTAAGAATTCTGCTGCATATATTTTT 961 AGCCCCATCTCCTGCCACTGCTGACAGATATTGTGACAGTAAGTAGCAGACAGGACTGTGGCTTCACCTCCTCCGGGCAC 1041 CTGGCTACAGTGATGAGTCAGTTCACCTGATGACAAACCAGGGTCTGGCCTTGCCAAAGCACTTAAGTTCTCATGACCTG 1121 GACCGCACTGGAGGCCCTGGCTAAGTCAGGATGTCGTAGCCTCTTCTTGGTTTTGCCCCTTGGCCTTGAAATTCTTTTTT 1201 CTTGAATAACTTTAAAAAAATAGAGATAAAGTCTTGCTATGTTGCCCAGGCTGGTCTTGAATGCCTGGGCTCCAGCAATC 1281 TTTTTGCCTCAACTTCCCAAAGTATTGAGATTACAGGTGTGAGCTACCATGCCCGGCCTTGAAATTCTTTCTTCGCTATG 1361 TCTGCATGTTTTTTGTGTTCTGTATTTATTTCTTCTCCAAGGAAACAGCCTACATTTTCCATGTGTCCATGTTTCTGAGG 1441 CCGTGGGTGACAGTGGGAATTGCACTAATGGGGGCCCAACAGGCCTGGGGGCTGGTCTTAGCGCTAGACCTTGAACAAGG 1521 CACTTCACCTGCTGGTCTCCAATTTTCTCCTCTGTAAAATGAAAGAGTTGAACTAAGTGATCTCAAAAGTTTCAACCAGC 1601 CCGATAATTCCTTAATTCTTTAAAAATTTAACTTTATATATCTTTATTATTCTTTAACCTCATCTTTGTTACACTAATAT 1681 TAGTCACTAATATTTATTGAGTGTTTACTACCTGACAGGCAGAGTGCCAGTTTACATTTTAATTTTCACATCATTTCTAT 1761 GATGTGGGTACTCATTTTTTTAAAGCTTTATGAAGGTATAATTTACGTACTATAAAATTCACCTGTTTTAAGTGTTCAGT 1841 TGAATGATTTTTAATTTACATAGTGGTGCAACCATCAATGATGTGGGTATTCTTACCCCAATTTAAAAGATAAGAAGGGG 1921 CAGTGTTAAGTAATTGACCCATGATTCCACAGCTAGTAAGAGCGACAGCCAAGACTCCAAACCTGGTTGATGCTCTTAAC 2001 CACTGTGCTATGCCGCAGGTAGGCAGATTCATTACTGCCTTATCTGAAACCCTTTGCACAGTTTCTATTACTGATTTCTA 2081 TGTAGATTTGAATATAACAAATTTAAATCATGTCCTTGGTAACAGAACTGATCACAGCCAAAAAAAATTCACCAAATGGG 2161 TTTATTCTGTACTCCAATATAGGTGTCTTCCCAGGTTTATATCCTTGGCTTGAGAAAAGGGTTGTACAAATAGATGATTG 2241 CAGAGTTTCCACATCCTTCCAGATACCTCTGCCTCTAGCAGTCACACTCTTAGTAAGGGAAGTTGTTTGATTTACTTCTT 2321 CCCTTAGGTTGATTACAAGTGAAGTGCGCCGTCTTATTCCTTTTTCATTGCTGGAGCACAAATTGAATTGTGCCCAGACC 2401 GTATCTTTCTCACATGAAACCTGGATCTCACCTATCCCTTCCATGCCTGATTCCCGTGTTTGCATATTTTATTTCCACAT 2481 TTACCTCTTGTCAGCCCTGACAGAGAATTTGGCACCCCTTCAAGCTTCTCCTAAACAATCTATGCACACAAACACCCCTG 2561 AGCAATATGGACTTCACTGAAGATAGTGTGTAAGCAAAGGAGAAGAGTTCACATTGTGCATCCTATTAGACATTTTGTTC 2641 TCAGAAGTACCTTACTGGCCAAACCAATGAAGGTTTTCCTCTTGTCCTCCCCTCTCAAGGCTCAGTCACCTCAACTTCTT 2721 TTTGCCTACTAGATATCCAATCCATCACCTCGCCTCCCCTGGCCCTAGCTCAATTACCCTCTTAAACCCATTCCTGCTCA 2801 GCAAAACTTCCTCTAGTTCACCATTCATTCATTTGAACATTAGGAGGCAATTTAGTGACCTGTTGTACCTGACCATGTTC 2881 TTAAGGGGGAGGTCTCACGTCTCATTCCCAGAAAAGTCTACCATATATAGATACATATTCCCCGCCCCGCCCCAGATTTC 2961 TGGTGAATGAAATCACTTGTATCTTATTAGGTACATATACGCAAATCCTTAACCTCAATTCTCTGTCCTCTTCATGTCTT 3041 ACCCAGATATCTCAGGAAGATTTCTCTTTTCCTTCTGTTTGCCTCCCTCTTCGACTTACTTGGGAGTCAGCATCTGACCA 3121 CAGTCGTGACTGGTAATGATGATTTGTGCAAATACTATCAAGGAAAGGACATGAATTGTCTTAATTTTAGACCCATTAAA 3201 AAACCGCACAGGCCTCAATCTTAAAAGTCCTATCTAAATACCCAGAAATACCCTTCAGAATTTTTGAAGCTATGCCCATG 3281 TACAAAATTTTCTTCCTTCCCTAATTTTAATGGTATACTAACACCTTAGGTAAATAAAATATTTCTTTACTATTTTATTG 3361 AAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-3 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796039. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796039 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000318833.3 | 3UTR | UUGGCACCCCUUCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
107 hsa-miR-100-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT105690 | LEPROTL1 | leptin receptor overlapping transcript like 1 | 2 | 2 | ||||||||
MIRT151558 | HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U like 1 | 2 | 4 | ||||||||
MIRT167753 | SGK1 | serum/glucocorticoid regulated kinase 1 | 2 | 2 | ||||||||
MIRT195380 | CBFB | core-binding factor beta subunit | 2 | 2 | ||||||||
MIRT283995 | DNAJA2 | DnaJ heat shock protein family (Hsp40) member A2 | 2 | 2 | ||||||||
MIRT317145 | E2F3 | E2F transcription factor 3 | 2 | 4 | ||||||||
MIRT380785 | ZFP3 | ZFP3 zinc finger protein | 2 | 2 | ||||||||
MIRT380927 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT441600 | ABCB5 | ATP binding cassette subfamily B member 5 | 2 | 6 | ||||||||
MIRT443896 | NUDT3 | nudix hydrolase 3 | 2 | 4 | ||||||||
MIRT444030 | GREM1 | gremlin 1, DAN family BMP antagonist | 2 | 4 | ||||||||
MIRT444112 | CEPT1 | choline/ethanolamine phosphotransferase 1 | 2 | 2 | ||||||||
MIRT444169 | ZNF701 | zinc finger protein 701 | 2 | 2 | ||||||||
MIRT444366 | TIMM8B | translocase of inner mitochondrial membrane 8 homolog B | 2 | 2 | ||||||||
MIRT444371 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 2 | ||||||||
MIRT444517 | ZNF525 | zinc finger protein 525 | 2 | 2 | ||||||||
MIRT444525 | CNIH4 | cornichon family AMPA receptor auxiliary protein 4 | 2 | 2 | ||||||||
MIRT444529 | EIF2A | eukaryotic translation initiation factor 2A | 2 | 2 | ||||||||
MIRT444537 | PHKB | phosphorylase kinase regulatory subunit beta | 2 | 2 | ||||||||
MIRT444702 | GATSL2 | cytosolic arginine sensor for mTORC1 subunit 2 | 2 | 2 | ||||||||
MIRT444717 | CMSS1 | cms1 ribosomal small subunit homolog (yeast) | 2 | 2 | ||||||||
MIRT444730 | TMC7 | transmembrane channel like 7 | 2 | 2 | ||||||||
MIRT444777 | NAPEPLD | N-acyl phosphatidylethanolamine phospholipase D | 2 | 2 | ||||||||
MIRT444802 | TMEM251 | transmembrane protein 251 | 2 | 2 | ||||||||
MIRT444995 | LRRC57 | leucine rich repeat containing 57 | 2 | 2 | ||||||||
MIRT445073 | C16orf87 | chromosome 16 open reading frame 87 | 2 | 2 | ||||||||
MIRT445250 | SEMA5A | semaphorin 5A | 2 | 2 | ||||||||
MIRT445336 | KATNAL1 | katanin catalytic subunit A1 like 1 | 2 | 2 | ||||||||
MIRT445426 | TPT1 | tumor protein, translationally-controlled 1 | 2 | 4 | ||||||||
MIRT445469 | TRIM13 | tripartite motif containing 13 | 2 | 2 | ||||||||
MIRT445646 | NPY4R | neuropeptide Y receptor Y4 | 2 | 2 | ||||||||
MIRT445759 | AGO1 | argonaute 1, RISC catalytic component | 2 | 2 | ||||||||
MIRT445838 | SRSF11 | serine and arginine rich splicing factor 11 | 2 | 2 | ||||||||
MIRT445868 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | 2 | 2 | ||||||||
MIRT446368 | STX16 | syntaxin 16 | 2 | 2 | ||||||||
MIRT446444 | THYN1 | thymocyte nuclear protein 1 | 2 | 2 | ||||||||
MIRT446593 | TASP1 | taspase 1 | 2 | 2 | ||||||||
MIRT446926 | SRSF7 | serine and arginine rich splicing factor 7 | 2 | 2 | ||||||||
MIRT447121 | SLFN5 | schlafen family member 5 | 2 | 2 | ||||||||
MIRT447196 | CDCP1 | CUB domain containing protein 1 | 2 | 2 | ||||||||
MIRT447358 | STOM | stomatin | 2 | 2 | ||||||||
MIRT447361 | FAM161B | family with sequence similarity 161 member B | 2 | 2 | ||||||||
MIRT447374 | NUP205 | nucleoporin 205 | 2 | 2 | ||||||||
MIRT447467 | OSMR | oncostatin M receptor | 2 | 2 | ||||||||
MIRT447606 | MRPL3 | mitochondrial ribosomal protein L3 | 2 | 2 | ||||||||
MIRT447682 | ASPA | aspartoacylase | 2 | 2 | ||||||||
MIRT447715 | ERP44 | endoplasmic reticulum protein 44 | 2 | 2 | ||||||||
MIRT447814 | EMX1 | empty spiracles homeobox 1 | 2 | 2 | ||||||||
MIRT447855 | RRP8 | ribosomal RNA processing 8 | 2 | 4 | ||||||||
MIRT447866 | KIAA1244 | ARFGEF family member 3 | 1 | 1 | ||||||||
MIRT447890 | STRIP2 | striatin interacting protein 2 | 2 | 2 | ||||||||
MIRT447916 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 2 | 2 | ||||||||
MIRT447935 | DUSP4 | dual specificity phosphatase 4 | 2 | 2 | ||||||||
MIRT448813 | GABRB1 | gamma-aminobutyric acid type A receptor beta1 subunit | 2 | 2 | ||||||||
MIRT448927 | CKS1B | CDC28 protein kinase regulatory subunit 1B | 2 | 2 | ||||||||
MIRT449105 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT449216 | ZNHIT3 | zinc finger HIT-type containing 3 | 2 | 2 | ||||||||
MIRT449336 | ACTBL2 | actin, beta like 2 | 2 | 2 | ||||||||
MIRT449675 | SOX3 | SRY-box 3 | 2 | 2 | ||||||||
MIRT449724 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT449768 | PRAMEF7 | PRAME family member 7 | 2 | 2 | ||||||||
MIRT449804 | PRAMEF8 | PRAME family member 8 | 2 | 2 | ||||||||
MIRT449850 | BCL2L13 | BCL2 like 13 | 2 | 2 | ||||||||
MIRT449866 | POFUT2 | protein O-fucosyltransferase 2 | 2 | 2 | ||||||||
MIRT450067 | SYT9 | synaptotagmin 9 | 2 | 2 | ||||||||
MIRT450197 | ZHX3 | zinc fingers and homeoboxes 3 | 2 | 2 | ||||||||
MIRT450386 | TENM4 | teneurin transmembrane protein 4 | 2 | 2 | ||||||||
MIRT450435 | PAX8 | paired box 8 | 2 | 2 | ||||||||
MIRT450716 | PVRL3 | nectin cell adhesion molecule 3 | 2 | 2 | ||||||||
MIRT495906 | PGM2L1 | phosphoglucomutase 2 like 1 | 2 | 2 | ||||||||
MIRT497543 | PPTC7 | PTC7 protein phosphatase homolog | 2 | 2 | ||||||||
MIRT497630 | ZNF576 | zinc finger protein 576 | 2 | 2 | ||||||||
MIRT497756 | OXGR1 | oxoglutarate receptor 1 | 2 | 2 | ||||||||
MIRT498072 | SLC25A12 | solute carrier family 25 member 12 | 2 | 2 | ||||||||
MIRT500542 | XPO4 | exportin 4 | 2 | 4 | ||||||||
MIRT500848 | SYPL1 | synaptophysin like 1 | 2 | 4 | ||||||||
MIRT511621 | HIST1H3J | histone cluster 1 H3 family member j | 2 | 4 | ||||||||
MIRT513745 | PKNOX1 | PBX/knotted 1 homeobox 1 | 2 | 2 | ||||||||
MIRT535077 | PPP1CB | protein phosphatase 1 catalytic subunit beta | 2 | 2 | ||||||||
MIRT543133 | ZFP36L1 | ZFP36 ring finger protein like 1 | 2 | 2 | ||||||||
MIRT544518 | GTF2E2 | general transcription factor IIE subunit 2 | 2 | 2 | ||||||||
MIRT544666 | MED19 | mediator complex subunit 19 | 2 | 2 | ||||||||
MIRT545407 | KIAA1715 | lunapark, ER junction formation factor | 2 | 2 | ||||||||
MIRT547569 | LRIG3 | leucine rich repeats and immunoglobulin like domains 3 | 2 | 4 | ||||||||
MIRT548767 | CNN3 | calponin 3 | 2 | 2 | ||||||||
MIRT551009 | TRIM4 | tripartite motif containing 4 | 2 | 2 | ||||||||
MIRT555077 | PURG | purine rich element binding protein G | 2 | 2 | ||||||||
MIRT560753 | ZNF616 | zinc finger protein 616 | 2 | 2 | ||||||||
MIRT563752 | FOXO3 | forkhead box O3 | 2 | 2 | ||||||||
MIRT565531 | SON | SON DNA binding protein | 2 | 2 | ||||||||
MIRT613933 | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 | 2 | 2 | ||||||||
MIRT614433 | TAZ | tafazzin | 2 | 2 | ||||||||
MIRT622520 | RAP2A | RAP2A, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT626037 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT648459 | LEAP2 | liver enriched antimicrobial peptide 2 | 2 | 2 | ||||||||
MIRT654982 | PLCXD3 | phosphatidylinositol specific phospholipase C X domain containing 3 | 2 | 4 | ||||||||
MIRT689103 | ZBTB25 | zinc finger and BTB domain containing 25 | 2 | 2 | ||||||||
MIRT704259 | DHCR24 | 24-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT711194 | CXCL3 | C-X-C motif chemokine ligand 3 | 2 | 2 | ||||||||
MIRT713315 | VLDLR | very low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT717266 | BMPR2 | bone morphogenetic protein receptor type 2 | 4 | 2 | ||||||||
MIRT718248 | CCDC18 | coiled-coil domain containing 18 | 2 | 2 | ||||||||
MIRT721944 | NGRN | neugrin, neurite outgrowth associated | 2 | 2 | ||||||||
MIRT721948 | IL1RAPL1 | interleukin 1 receptor accessory protein like 1 | 2 | 2 | ||||||||
MIRT734969 | PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 | 3 | 0 | ||||||||
MIRT735945 | NME2 | NME/NM23 nucleoside diphosphate kinase 2 | 0 | 0 | ||||||||
MIRT737404 | HOXA1 | homeobox A1 | 4 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|